Cipla Ltd.

₹1505.9

Cipla Ltd.

₹1505.9

₹1505.9

3.5 (0.23%) - 30 Jun 2025 04:29 PM

About Company

Cipla Limited, established in 1935, is a global pharmaceutical company with a strong commitment to make medicines accessible and affordable to those in need. The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS and various other key therapeutic segments. With a rich portfolio, the company is deepening its presence in the home markets of India, as well as South Africa, North America and other key regulated and emerging markets.

Market Cap. ₹ 121,639 Cr.
52 Week - High/Low ₹ 1,702/1,335
P/E Ratio 23.52
P/B Ratio 3.78
Enterprise Value ₹ 121,341 Cr.
ROE % 17.2
RSI Value 50.95
EMA 50 1495.46
EMA 200 1485.28
Market Cap. ₹ 121,639 Cr.
52 Week - High/Low ₹ 1,702/1,335
P/E Ratio 23.01
P/B Ratio 3.89
Enterprise Value ₹ 120,526 Cr.
ROE % 18.34
RSI Value 50.95
EMA 50 1495.46
EMA 200 1485.28

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.